Bio Sequence

Efficient Strategies for Acquiring Sequence Information for an Antibody by Its Name

16 November 2023
2 min read

This article will teach you three methods to find the corresponding sequence information by the name of an antibody.

Method 1: Search Through the Patsnap Synapse Global Innovative Drug Intelligence Database (synapse.patsnap.com)

Enter the drug search interface of the Synapse Intelligence New Drug Information Database and search for the drug using the antibody name. If the antibody sequence has been disclosed by the original research company, you can view the sequence information on the drug detail page.

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

表格

描述已自动生成

Method 2: Search Through the Patsnap Bio Sequence Database (bio.patsnap.com)

Create a free account in the Patsnap Bio Sequence Database. On the database homepage, in the drug/gene index section, search for the drug using the antibody name. If the antibody sequence has been disclosed by the original research company, you can find the antibody sequence information with a single search.

图形用户界面, 文本, 应用程序

描述已自动生成

Method 3: For Sequences of Early-Stage Antibody Drugs, Search Through the Patent Analytics Database (patsnap.com)

First, find the original research company and target for the antibody drug in the Patsnap Synapse Drug Database. Then, set up a keyword search in the Patent Analytics Database to find the original research patents. Conduct sequence analysis and searching within these patents.

图形用户界面, 文本, 应用程序, Teams

描述已自动生成

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 应用程序

描述已自动生成

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated, illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is available for the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

What are CD38 inhibitors and how do you quickly get the latest development progress?
What are CD38 inhibitors and how do you quickly get the latest development progress?
16 November 2023
Inhibitors of CD38 are a kind of treatment aimed at the white blood cells within bone marrow, which are responsible for inducing multiple myeloma.
Read →
Cadonilimab: brief review of its R&D progress and the clinical result in 2023 ESMO
ESMO 2023
4 min read
Cadonilimab: brief review of its R&D progress and the clinical result in 2023 ESMO
16 November 2023
On 23 Oct 2023, the phase Ib/II clinical trial result of Cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma was reported at the ESMO Congress.
Read →
Monte Rosa Therapeutics reveals preclinical results, suggesting that MRT-6160, could treat immune-based and inflammatory disorders
Latest Hotspot
3 min read
Monte Rosa Therapeutics reveals preclinical results, suggesting that MRT-6160, could treat immune-based and inflammatory disorders
16 November 2023
Monte Rosa Therapeutics unveils preclinical findings. The research indicates that MRT-6160, a VAV1-specific molecular glue breaker, may be effective in treating immune-based and inflammatory disorders.
Read →
What are calcineurin inhibitors and how do you quickly get the latest development progress?
What are calcineurin inhibitors and how do you quickly get the latest development progress?
16 November 2023
Calcineurin inhibitors, acting as immunosuppressive agents, are employed in the treatment of autoimmune disorders like lupus nephritis, atopic dermatitis, interstitial lung disease, and idiopathic inflammatory myositis, among others.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.